Garstang Medical Services Limited - Period Ending 2017-03-31

Garstang Medical Services Limited - Period Ending 2017-03-31


Garstang Medical Services Limited 05015346 false 2016-04-01 2017-03-31 2017-03-31 The principal activity of the company is a dispensing pharmacy Digita Accounts Production Advanced 6.20.8420.0 Software true 05015346 2016-04-01 2017-03-31 05015346 2017-03-31 05015346 core:CapitalRedemptionReserve 2017-03-31 05015346 core:RetainedEarningsAccumulatedLosses 2017-03-31 05015346 core:ShareCapital 2017-03-31 05015346 core:CurrentFinancialInstruments 2017-03-31 05015346 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 05015346 core:Non-currentFinancialInstruments core:AfterOneYear 2017-03-31 05015346 core:FurnitureFittingsToolsEquipment 2017-03-31 05015346 core:LandBuildings 2017-03-31 05015346 core:MotorVehicles 2017-03-31 05015346 core:OtherPropertyPlantEquipment 2017-03-31 05015346 bus:SmallEntities 2016-04-01 2017-03-31 05015346 bus:AuditExemptWithAccountantsReport 2016-04-01 2017-03-31 05015346 bus:FullAccounts 2016-04-01 2017-03-31 05015346 bus:RegisteredOffice 2016-04-01 2017-03-31 05015346 bus:Director1 2016-04-01 2017-03-31 05015346 bus:Director3 2016-04-01 2017-03-31 05015346 bus:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31 05015346 bus:Agent1 2016-04-01 2017-03-31 05015346 core:FurnitureFittings 2016-04-01 2017-03-31 05015346 core:FurnitureFittingsToolsEquipment 2016-04-01 2017-03-31 05015346 core:LandBuildings 2016-04-01 2017-03-31 05015346 core:MotorVehicles 2016-04-01 2017-03-31 05015346 core:OtherPropertyPlantEquipment 2016-04-01 2017-03-31 05015346 core:PlantMachinery 2016-04-01 2017-03-31 05015346 countries:UnitedKingdom 2016-04-01 2017-03-31 05015346 2016-03-31 05015346 core:FurnitureFittingsToolsEquipment 2016-03-31 05015346 core:LandBuildings 2016-03-31 05015346 core:MotorVehicles 2016-03-31 05015346 core:OtherPropertyPlantEquipment 2016-03-31 05015346 2015-04-01 2016-03-31 05015346 2016-03-31 05015346 core:CapitalRedemptionReserve 2016-03-31 05015346 core:RetainedEarningsAccumulatedLosses 2016-03-31 05015346 core:ShareCapital 2016-03-31 05015346 core:CurrentFinancialInstruments 2016-03-31 05015346 core:CurrentFinancialInstruments core:WithinOneYear 2016-03-31 05015346 core:Non-currentFinancialInstruments core:AfterOneYear 2016-03-31 05015346 core:FurnitureFittingsToolsEquipment 2016-03-31 05015346 core:LandBuildings 2016-03-31 05015346 core:MotorVehicles 2016-03-31 05015346 core:OtherPropertyPlantEquipment 2016-03-31 iso4217:GBP xbrli:pure

REGISTRAR OF COMPANIES

Registration number: 05015346

Garstang Medical Services Limited

Unaudited Financial Statements

31 March 2017

image-name

 

Garstang Medical Services Limited

Contents

Accountants' Report

1

Balance Sheet

2

Notes to the Financial Statements

4

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Garstang Medical Services Limited
for the Year Ended 31 March 2017

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Garstang Medical Services Limited for the year ended 31 March 2017 as set out on pages 2 to 9 from the company's accounting records and from information and explanations you have given us.

As a member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/membershandbook.

This report is made solely to the Board of Directors of Garstang Medical Services Limited, as a body, in accordance with the terms of our engagement letter dated 1 May 2013. Our work has been undertaken solely to prepare for your approval the accounts of Garstang Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Garstang Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Garstang Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Garstang Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Garstang Medical Services Limited. You consider that Garstang Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Garstang Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



Dodd & Co Limited
Chartered Accountants
Clint Mill
Cornmarket
PENRITH
CA11 7HW

20 July 2017

 

Garstang Medical Services Limited

(Registration number: 05015346)
Balance Sheet as at 31 March 2017

Note

2017
£

2016
£

Fixed assets

 

Tangible assets

4

47,864

55,098

Current assets

 

Stocks

82,240

85,310

Debtors

5

810,527

782,753

Cash and cash equivalents

 

107,334

12,164

 

1,000,101

880,227

Creditors: Amounts falling due within one year

6

(1,039,663)

(929,636)

Net current liabilities

 

(39,562)

(49,409)

Total assets less current liabilities

 

8,302

5,689

Creditors: Amounts falling due after more than one year

6

(177)

(477)

Provisions for liabilities

(1,662)

(2,269)

Net assets

 

6,463

2,943

Capital and reserves

 

Allotted, called up and fully paid share capital

350

350

Capital redemption reserve

125

125

Profit and loss account

5,988

2,468

Total equity

 

6,463

2,943

 

Garstang Medical Services Limited

(Registration number: 05015346)
Balance Sheet as at 31 March 2017 (continued)

For the financial year ending 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 20 July 2017 and signed on its behalf by:
 

.........................................

Dr J T Williamson

Director

.........................................

Dr M E John

Director

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Garstang Medical Centre
Kepple Lane
Garstang
PRESTON
PR3 1PB

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company has net current liabilities at 31 March 2017 and meets its day to day working capital requirements through its bank overdraft facility which, in common with all such facilities, is repayable on demand. In addition the directors have provided financial support by way of short term loans. On the basis of this support, the directors consider it appropriate to prepare the financial statements on the going concern basis.

However, should the company not have the support of its bankers, and therefore be unable to continue trading, adjustments would have to be made to reduce the value of assets to their recoverable amounts, to provide for any further liabilities which might arise, and to reclassify fixed assets and long term liabilities as current assets and current liabilities.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.


Other grants
Other grants in respect of capital expenditure are credited to a deferred income account and are released to profit over the expected useful lives of the relevant assets on a basis consistent with the depreciation policy.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017 (continued)

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

15% straight line

Fixtures and fittings

15% straight line

Land and buildings

Straight line over 24 years

Motor vehicles

25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for the sale of goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017 (continued)

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method where due after more than one year.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017 (continued)

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 47 (2016 - 43).

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017 (continued)

4

Tangible assets

Land and buildings
£

Plant and equipment
 £

Motor vehicles
 £

Furniture, fittings and office equipment
 £

Total
£

Cost or valuation

At 1 April 2016

60,036

69,251

14,075

35,958

179,320

Additions

-

-

-

554

554

At 31 March 2017

60,036

69,251

14,075

36,512

179,874

Depreciation

At 1 April 2016

22,518

61,961

9,908

29,835

124,222

Charge for the year

2,502

2,503

1,042

1,741

7,788

At 31 March 2017

25,020

64,464

10,950

31,576

132,010

Carrying amount

At 31 March 2017

35,016

4,787

3,125

4,936

47,864

At 31 March 2016

37,518

7,290

4,167

6,123

55,098

5

Debtors

2017
£

2016
£

Trade debtors

756,742

735,877

Other debtors

53,785

46,876

810,527

782,753

6

Creditors

Note

2017
£

2016
£

Due within one year

 

Loans and borrowings

7

-

6,025

Trade creditors

 

960,071

863,137

Taxation and social security

 

12,343

12,665

Corporation tax liability

 

58,836

38,995

Other creditors

 

8,413

8,814

 

1,039,663

929,636

Due after one year

 

Other creditors

 

177

477

 

Garstang Medical Services Limited

Notes to the Financial Statements for the Year Ended 31 March 2017 (continued)

7

Loans and borrowings

2017
£

2016
£

Current loans and borrowings

Bank borrowings

-

6,025

Current loans and borrowings have been secured by the company.